- Home
- DSS vs SNSE Comparison
DSS vs SNSE Comparison
Compare DSS & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSS
- SNSE
- Stock Information
- Founded
- DSS 1984
- SNSE 2005
- Country
- DSS United States
- SNSE United States
- Employees
- DSS N/A
- SNSE N/A
- Industry
- DSS Containers/Packaging
- SNSE Biotechnology: Pharmaceutical Preparations
- Sector
- DSS Consumer Discretionary
- SNSE Health Care
- Exchange
- DSS Nasdaq
- SNSE Nasdaq
- Market Cap
- DSS 11.7M
- SNSE 10.3M
- IPO Year
- DSS N/A
- SNSE 2021
- Fundamental
- Price
- DSS $1.06
- SNSE $8.80
- Analyst Decision
- DSS
- SNSE Strong Buy
- Analyst Count
- DSS 0
- SNSE 5
- Target Price
- DSS N/A
- SNSE $72.50
- AVG Volume (30 Days)
- DSS 20.2K
- SNSE 34.2K
- Earning Date
- DSS 11-14-2025
- SNSE 11-14-2025
- Dividend Yield
- DSS N/A
- SNSE N/A
- EPS Growth
- DSS N/A
- SNSE N/A
- EPS
- DSS N/A
- SNSE N/A
- Revenue
- DSS $22,046,000.00
- SNSE N/A
- Revenue This Year
- DSS N/A
- SNSE N/A
- Revenue Next Year
- DSS N/A
- SNSE N/A
- P/E Ratio
- DSS N/A
- SNSE N/A
- Revenue Growth
- DSS 6.53
- SNSE N/A
- 52 Week Low
- DSS $0.72
- SNSE $5.00
- 52 Week High
- DSS $1.90
- SNSE $18.35
- Technical
- Relative Strength Index (RSI)
- DSS 30.83
- SNSE 48.12
- Support Level
- DSS $1.00
- SNSE $7.56
- Resistance Level
- DSS $1.25
- SNSE $10.30
- Average True Range (ATR)
- DSS 0.07
- SNSE 0.88
- MACD
- DSS -0.02
- SNSE -0.07
- Stochastic Oscillator
- DSS 4.00
- SNSE 59.85
About DSS DSS Inc.
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).